Anchor Center For Blind Children Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2550 Roslyn St, Denver, CO 80238 Phone: 303-377-9732 Fax: 303-377-9744 |
Mary Chason Gunn, M.S., SLP-CF Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1500 Little Raven St, Denver, CO 80202 Phone: 720-360-4500 |
Mercedes Case Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1777 Larimer St, Denver, CO 80202 Phone: 845-532-4395 |
Kirsten Pavlovics Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1860 N Lincoln St, Denver, CO 80203 Phone: 720-423-3200 |
Karen E Duerk, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1150 Galapago St, Apt 611, Denver, CO 80204 Phone: 720-530-0175 |
Marcie L Mcneill, MA/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 411 S Gilpin St, Denver, CO 80209 Phone: 303-325-7386 |
Brooke Gordon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Leetsdale Dr, Denver, CO 80224 Phone: 303-331-9963 |
Erica Mills Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1860 N Lincoln St, Denver, CO 80203 Phone: 305-785-4979 |
Amanda Marie Kraemer, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 E Iliff Ave, Denver, CO 80222 Phone: 303-757-5441 |
Brianne Gerbino Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4500 E Cherry Creek South Dr, Denver, CO 80246 Phone: 303-432-8487 |
Emily Jeanette Stevenson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4500 E Cherry Creek South Dr Ste 710, Denver, CO 80246 Phone: 303-432-8487 |
Robert Abrams Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Pennsylvania St Apt 304, Denver, CO 80203 Phone: 303-861-1890 |
Jennifer Jaramillo Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Leetsdale Dr, Denver, CO 80224 Phone: 303-331-9963 |
Leslie Crump Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1860 N Lincoln St, Denver, CO 80203 Phone: 419-544-4298 |
Sara Fawver, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4450 E Jewell Ave, Denver, CO 80222 Phone: 303-757-7438 |
Mary Kenz, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1143 Ivy St, Denver, CO 80220 Phone: 626-261-3046 Fax: 303-904-7615 |
Maria Buteyn Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7350 Broadway, Denver, CO 80221 Phone: 303-853-1617 |
Alicia Marie Suschena Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4500 E Cherry Creek South Dr Ste 710, Denver, CO 80246 Phone: 303-432-8487 |
Dr. Marilyn Faye Selinger, PH.D. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 290 Dexter St, Denver, CO 80220 Phone: 303-909-7995 Fax: 303-355-4574 |
Adelante Speech Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 270 Delaware St, Denver, CO 80223 Phone: 720-273-2140 |
News Archive
Oncotarget published "Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer" which reported that although early detection and diagnosis are indispensable for improving the prognosis of patients with pancreatic cancer, both have yet to be achieved.
Researchers from the University of Missouri School of Medicine have found that drinking alcohol to fall asleep interferes with sleep homeostasis, the body's sleep-regulating mechanism.
Two new drugs have gained approval from the US Food and Drug Administration (FDA) – one is an antibiotic from Forest Labs and the other a first-time treatment for a neurological disorder developed by Avanir Pharmaceuticals. Another waiting for approval is Biodel's fast-acting insulin Linjeta. On the other hand seven new drugs got rejected including a diabetes drug from Amylin Pharmaceuticals and weight-loss drugs from Arena Pharmaceuticals and Vivus, respectively.
Universal Biosensors announced today that it has agreed amendments to its arrangements with Siemens Healthcare Diagnostics Inc. The parties have agreed to shift the focus of their joint product development activities, provide prepayment of milestones to UBI and improved strip pricing to support Siemens' entry into the point-of-care PT-INR testing market.
› Verified 1 days ago